Read More Analyst Ratings News Price Target Truist Securities Maintains Buy on Roku, Lowers Price Target to $90 By Benzinga Newsdesk August 26, 9:41 AM Truist Securities analyst Matthew Thornton maintains Roku (NASDAQ:ROKU) with a Buy and lowers the price target from $120 to $90. ROKU
Read More Equities General IPOs News Small Cap What’s Going On With Recently Listed Security Services Company SU Group Shares Today? By Lekha Gupta January 26, 11:13 AM SU Group Holdings recently made its debt, pricing its IPO at $4.00 per share, representing the lower end of its planned $4.00-$5.00 range. SUGP
Read More Analyst Ratings News Price Target Keybanc Maintains Overweight on Inspire Medical Systems, Raises Price Target to $303 By Benzinga Newsdesk January 13, 5:29 AM Keybanc analyst Matthew Mishan maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and raises the price target from $287 to $303. INSP
Read More Biotech General News Cellectar Biosciences Expands A New Licensing Agreement With The Wisconsin Alumni Research Foundation For Intellectual Property That Was The Result Of Collaborative Research With Iopofosine I 131 In Pediatric Cancers By Benzinga Newsdesk December 19, 9:33 AM Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced a new licensing CLRB